Annovis Bio, Inc. (NYSE: ANVS) last traded at $1.21, up 3.42% on the session. The quote above updates while this page is open; the figures below are drawn from Annovis Bio, Inc.’s own filings and are restated only when a new one is published.
Annovis Bio, Inc. trades on NYSE under the ticker ANVS. Its market capitalisation is $51.55 million.
Valuation measures for Annovis Bio, Inc., derived from the latest quote and its most recent SEC filing.
| Market cap | $51.55M |
|---|---|
| Enterprise value | $59.12M |
| Beta | 1.48 |
Trailing-twelve-month figures tagged in Annovis Bio, Inc.'s XBRL filings with the SEC.
| Revenue (TTM) | $0.00 |
|---|---|
| Net income (TTM) | -$49.52M |
| Cash | $18.73M |
|---|
Range and volume for ANVS over the past 52 weeks.
| 52-week high | $5.50 |
|---|---|
| 52-week low | $1.04 |
| Volume | 521.9K |
| Average volume | 879.2K |
| Previous close | $1.17 |
Invest a chosen dollar amount in Annovis Bio, Inc. with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell ANVS.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.